首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >Biocompatible chitosan-zinc oxide nanocomposite based dispersive micro-solid phase extraction coupled with HPLC-UV for the determination of rosmarinic acid in the extracts of medical plants and water sample
【24h】

Biocompatible chitosan-zinc oxide nanocomposite based dispersive micro-solid phase extraction coupled with HPLC-UV for the determination of rosmarinic acid in the extracts of medical plants and water sample

机译:基于生物相容性的壳聚糖 - 氧化锌基基的分散微固相萃取与HPLC-UV耦合,用于测定医用植物提取物和水样中的rosmarinic酸

获取原文
获取原文并翻译 | 示例
           

摘要

In the present research, a procedure was described for the recovery of rosmarinic acid (RA) from medical extract samples using chitosan-zinc oxide nanoparticles as a biocompatible nanocomposite (CS-ZnO-NC). The dispersive micro-solid phase extraction (D-mu-SPE) of RA from the medical extract samples was investigated by using the prepared biocompatible composite as a solid phase. The HPLC-UV method was used for measuring the extracted RA. The important variables (pH, biocompatible composite mass, contact time, and volume of eluent) associated with the extraction process were analyzed by the application of central composite design (CCD). The achieved optimum values for the mentioned variables were 7.0, 10 mg, 4 min, and 180 mu L, respectively. The extraction recovery (99.68%) obtained from the predicted model was in agreement with the experimental data (98.22 +/- 1.33%). In addition, under the obtained optimum conditions and over the concentration in the range of 2-3500 ng mL(-1), a linear calibration curve was obtained with R-2 > 0.993. The limit of detection (LOD) and quantification (LOQ) values were computed, and the obtained ranges were respectively from 0.060 to 0.089 ng mL(-1) and 0.201 to 0.297 ng mL(-1). In addition, the enrichment factors were obtained in the range of 93.7-110.5 with preconcentration factor of 83.3. Therefore, the D-mu-SPE-HPLC-UV method could be used for analyzing RA in the samples of the extracts obtained from the medical plants and water with the recovery values of the analyte in the range of 96.6%-105.4% and the precision with relative standard deviation <5.7%. (C) 2020 Elsevier B.V. All rights reserved.
机译:在本研究中,描述了使用壳聚糖 - 氧化锌纳米颗粒作为生物相容性纳米复合材料(CS-ZnO-NC)从医疗提取物样品中回收rosmarinic酸(Ra)的方法。通过使用制备的生物相容性复合物作为固相,研究了来自医疗提取物样品的RA的分散微固体相萃取(D-MU-SPE)。 HPLC-UV方法用于测量提取的RA。通过应用中央复合设计(CCD)分析了与提取过程相关的重要变量(pH,生物相容性复合质量,接触时间和洗脱液体积)。所提到的变量的最佳值分别为7.0,10mg,4分钟和180μl。从预测模型获得的提取恢复(99.68%)与实验数据一致(98.22 +/- 1.33%)一致。另外,在所获得的最佳条件下,在2-3500 ng ml(-1)范围内的浓度下,用R-2> 0.993获得线性校准曲线。计算检测(LOD)和定量(LOQ)值(LOD)值,并且所获得的范围分别为0.060至0.089ng ml(-1)和0.201至0.297 ng ml(-1)。此外,富集因子在93.7-110.5的范围内,具有83.3的前浓度为83.3。因此,D-MU-SPE-HPLC-UV方法可用于分析从医疗植物和水中获得的提取物的样品中的RA,其中分析物的回收值在96.6%-105.4%的范围内和精度相对标准偏差<5.7%。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号